Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, United States.
Department of Biological Sciences, University of Arkansas, Fayetteville, AR, United States.
Front Immunol. 2024 Aug 2;15:1269760. doi: 10.3389/fimmu.2024.1269760. eCollection 2024.
Bats harbor viruses that can cause severe disease and death in humans including filoviruses (e.g., Ebola virus), henipaviruses (e.g., Hendra virus), and coronaviruses (e.g., SARS-CoV). Bats often tolerate these viruses without noticeable adverse immunological effects or succumbing to disease. Previous studies have largely focused on the role of the bat's innate immune response to control viral pathogenesis, but little is known about bat adaptive immunity. A key component of adaptive immunity is the humoral response, comprised of antibodies that can specifically recognize viral antigens with high affinity. The antibody genes within the 1,400 known bat species are highly diverse, and these genetic differences help shape fundamental aspects of the antibody repertoire, including starting diversity and viral antigen recognition. Whether antibodies in bats protect, mediate viral clearance, and prevent transmission within bat populations is poorly defined. Furthermore, it is unclear how neutralizing activity and Fc-mediated effector functions contribute to bat immunity. Although bats have canonical Fc genes (e.g., mu, gamma, alpha, and epsilon), the copy number and sequences of their Fc genes differ from those of humans and mice. The function of bat antibodies targeting viral antigens has been speculated based on sequencing data and polyclonal sera, but functional and biochemical data of monoclonal antibodies are lacking. In this review, we summarize current knowledge of bat humoral immunity, including variation between species, their potential protective role(s) against viral transmission and replication, and address how these antibodies may contribute to population dynamics within bats communities. A deeper understanding of bat adaptive immunity will provide insight into immune control of transmission and replication for emerging viruses with the potential for zoonotic spillover.
蝙蝠携带的病毒可导致人类严重疾病和死亡,包括丝状病毒(如埃博拉病毒)、亨尼帕病毒(如亨德拉病毒)和冠状病毒(如 SARS-CoV)。蝙蝠通常能耐受这些病毒,而不会出现明显的免疫不良反应或死于疾病。先前的研究主要集中在蝙蝠固有免疫反应对控制病毒发病机制的作用上,但对蝙蝠适应性免疫知之甚少。适应性免疫的一个关键组成部分是体液免疫反应,由能够特异性识别高亲和力病毒抗原的抗体组成。在已知的 1400 种蝙蝠物种中,抗体基因高度多样化,这些遗传差异有助于塑造抗体库的基本方面,包括起始多样性和病毒抗原识别。蝙蝠体内的抗体是否能保护、介导病毒清除以及预防蝙蝠种群内的传播,目前还不清楚。此外,中和活性和 Fc 介导的效应功能如何有助于蝙蝠免疫也不清楚。尽管蝙蝠具有典型的 Fc 基因(如 mu、gamma、alpha 和 epsilon),但其 Fc 基因的拷贝数和序列与人类和小鼠的 Fc 基因不同。针对病毒抗原的蝙蝠抗体的功能是根据测序数据和多克隆血清推测的,但缺乏针对单克隆抗体的功能和生化数据。在这篇综述中,我们总结了蝙蝠体液免疫的现有知识,包括物种间的差异、它们在预防病毒传播和复制方面的潜在保护作用,并探讨了这些抗体如何有助于蝙蝠群体的种群动态。深入了解蝙蝠适应性免疫将为了解新兴病毒的传播和复制的免疫控制提供深入的见解,这些病毒有可能从动物传播给人类。